Abstract
The last two decades has seen progress in the development of potential mucoadhesive carriers for assisting with the oral and nasal administration of drugs based around the polysaccharide chitosan. This progress has been underpinned by the development of molecular assays for mucoadhesiveness focusing on the mucin component of mucus. We review the developments based around molecular or biophysical analyses and consider how the issue of product stability is now being addressed. Although the targets are pharmaceutical, the technology could be extended to the encapsulation and release of nutrients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
